Published: Dec, 2017

The key players in the global autologous cell therapy market include names such as Phamicell Co. Inc., BioTime Inc., Vericel Corporation, BrainStorm Cell Therapeutics, and Opexa Therapeutics among others. These players in the market are projected to concentrate on strategic business activities such as mergers, takeovers, joint ventures, and partnerships to enter into the local market. In addition to this, with a view to set up subsidiaries and manufacturing plants in the developing economies, the global market for autologous cell therapy is projected to become a highly competitive market space in the coming years of the given forecast period.

The overall valuation of the global market for autologous cell therapy in the year 2015 was found to be US$3.8 bn. This valuation is expected to grow and reach a figure worth US$23.7 bn by the fall of 2024. This growth of the global autologous cell therapy market is expected to be achieved with the help of an impressive CAGR of 21.9% during the course of the given forecast period of 2016 to 2024.

Depending on the type of source, the global market for autologous cell therapy can be segmented into epidermis and bone marrow. Of these, the global market is expected to be dominated by the segment of bone marrow, with it accounting a total valuation worth US$12.0 bn by the end of 2024.

With respect to geography, the global market for autologous cell therapy can be segmented into key regions such as Asia Pacific, North America, Latin America, Middle East and Africa, and Europe. Of these, the global market is projected to be dominated by North America owing to heavy investments in the treatment facilities. The North America market was valued at US$2.1 bn in the year 2015.

autologous cell therapy market

High Cancer Prevalence to Augment Market Development

The America Cancer Society states around a million people in the U.S. alone are found to have different kinds of cancer with every passing year. The World Health Organization expresses that there will be a 30% ascent in the quantity of cancer cases in the following decades. Moreover, radically changing ways of life that are characterized by the poor dietary decisions and stationary living are likewise anticipated that would contribute the taking off number of malignancy cases over the globe. Insights shared by International Agency for Research on Cancer (IARC) and WHO expressed that the event of growth has been on the consistent ascent among the geriatric populace. Besides, around 60% of the world's new disease cases are found to be in emerging regions of Asia, Africa, and Central America. These variables have set off a great demand for the autologous cell treatment for treating cancer and dealing with the illness.

Arguments over Ethics to Impede Market Growth

The heated argument over moral issues of the killing off embryos after the extraction of cells is the hardest test of the global autologous cell treatment market. In this way, the confinement on innovative work exercises relating to embryonic stems cells is foreseen to hamper the overall development of the general market. Besides, absence of proper repayment arrangements for those looking for cell treatment alongside the high cost of treatment is likewise anticipated that would confine the extension for development for the general market.

This review is based on the research report by Transparency Market Research titled, “Autologous Cell Therapy Market (Source - Bone Marrow and Epidermis; Application - Neurology, Orthopedics, Cancer, Wound Healing, CVD, and Autoimmune; End User - Hospitals, Ambulatory Centers, and Research Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024”

Market Segmentation:

  • Global Autologous Cell Therapy Market, by Source
    • Bone Marrow
    • Epidermis
    • Others 
  • Global Autologous Cell Therapy Market, by Application
    • Neurology
    • Orthopedic
    • Cancer
    • Wound Healing
    • CVD
    • Autoimmune
    • Others 
  • Global Autologous Cell Therapy Market, by End-user
    • Hospitals
    • Ambulatory Centers
    • Research Centers 
  • Global Autologous Cell Therapy Market, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Switzerland
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • Japan
      • China
      • India
      • Rest of APAC
    • Latin America (LATAM)
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa (MEA)
      • South Africa
      • Saudi Arabia
      • Rest of MEA

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453